-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
January 01, 2023 - Design
Appendix H. Key Question 2 Predictors
Table H-1. KQ2 Predictors of Treatment Efficacy
PMID First Author Publication Year Extractor Study Name/Database/RCT PMID/Site Followup Duration N Mean Age (SD) Baseline CY-BOCS Score, Mean (SD) Intervention Type Pharmacolgical Interventions, Drug Class (e.g., SSRI) Phar…
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
February 01, 2016 - be associated with
small, statistically nonsignificant effects vs. sham manipulation on
pain at 1 month … pain relief at 1 week (3 trials; WMD,
0.06 on a 0 to 10 scale; 95% CI, −0.53 to 0.65; I2 = 0%), 1 month … 95% CI, −0.73 to −0.10; I2 =
18%) vs. exercise or advice alone, but there were no differences at
1 month … pain relief at 1 week (3 trials; WMD,
0.06 on a 0 to 10 scale; 95% CI, −0.53 to 0.65; I2 = 0%), 1 month … Combination therapy was also associated with better function at 1
month, (2 trials; SMD, −0.40; 95%
-
effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
April 01, 2020 - on
nonpharmacologic interventions for chronic pain,5
which included studies with greater than 1 month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
January 30, 2014 - longitudinal$survey$of$soldiers$in$three$Brigade$Combat$Teams$was$conducted$1"2$months$prior$to$an$average$10"month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
January 01, 2017 - As discussed above, both groups
showed improvement in AHI at 6-month followup, with
maintenance at … 12-month followup (no significant group
differences). … collected quality of life data, which were not markedly
different between any of the study arms at the 24-month … fewer missed days
in tonsillectomy arms vs. no
surgery in 2 RCTs with medium
study limitations at 12 month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - This 12-month study did not report any
differences in harms between etanercept and infliximab. … comparative
effectiveness of anti-TNF therapy and methotrexate in
patients with psoriatic arthritis: 6 month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-evidence-summary.pdf
August 01, 2018 - Lifetime and 12-month
prevalence of bipolar spectrum disorder in the National
Comorbidity Survey replication … A placebo-controlled
18-month trial of lamotrigine and lithium maintenance treatment
in recently manic … A placebo-controlled
18-month trial of lamotrigine and lithium maintenance treatment
in recently depressed … A randomized,
placebo-controlled 12-month trial of divalproex and lithium
in treatment of outpatients
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
October 01, 2006 - Layout 1
Background
Renal artery stenosis (RAS) is defined as
the narrowing of the lumen of the renal
artery. Atherosclerosis accounts for 90
percent of cases of RAS. Atherosclerotic
RAS (ARAS) is a progressive disease that
may occur alone or in combination with
hypertension and ischemic kidney disease.
The prevalenc…
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - frequently reported high
intervention tolerance and acceptability.13,18
A 2013 Swiss study reported 3-month … measured by a decrease in number of patients
reporting a binge-drinking event (baseline: 75.5%; 3-month … message intervention to reduce
binge drinking in young adults: a randomized
controlled trial with 9-month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1
Systematic Review on Nonopioid
Pharmacologic Treatments for Chronic
Pain: Surveillance Report 1
Literature Update Period: September 2019 through September 2021
Background and Purpose
This is the first update for the…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - HbA1c is a measure of the average amount
of glucose in a patient’s blood over a 3- or 4-month period … The incidence of
incisional glaucoma surgery at month 36 was 4.8% in the low-dose group and 8.1% … The mean improvement in BCVA letter score between baseline and month 24
was 4.4 and 5.4 in the low- … These 24-month data were submitted in the manufacturer’s original 2010 FDA NDA. … The 36-month trial
results were provided to FDA in May 2011.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - pain
2018 AHRQ review: some nonpharmacologic treatments for chronic pain associated with sustained (>1 month
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: July 28, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Screening for and Management of Chronic Kidney
Disease Stages 1-3
I. Background and Objectives for the Systematic Review
T…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
October 11, 2019 - For re-
exacerbation, we extracted at the end of intervention,
1-month, 3 month, 6-month, 12-month, … within the first few days after hospital discharge, with
a time-related reduction in risk over a 12 month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
September 10, 2012 - Disposition of Comments Report for Breathing Exercises and/or Retraining Techniques in the Treatment of Asthma: Comparative Effectiveness
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1251
Published Online: September 10, 2012
Comparativ…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - retention requiring an indwelling catheter or
clean intermittent catheterization for at least 1
month … of the microwave therapy patients and 22 percent of the TURP patients experienced a
UTI over the 6-month … addressed one comparison relevant to
our review, immediate implant versus a delayed implant (i.e., 6-month … Gallien, et al. report the rate of UTI
at 6 month followup to be 35 percent in the botulinum patients
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
October 01, 2011 - celecoxib was superior to
diclofenac or ibuprofen for ulcer complications or
symptomatic ulcers at 6 month … There was no difference in rates of ulcer
complications or symptomatic ulcers at either 6
month or … celecoxib was
superior to diclofenac or ibuprofen for ulcer complications or
symptomatic ulcers at 6 month … However, CLASS found
no difference in rates of ulcer complications alone at either 6
month or complete … chondroitin
sulphate was associated with a steady
improvement in Lequesne ISK scores over the 3-
month
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - Twice a
month, the project staff will meet to discuss the results and progress to date; review cases
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - Twice a
month, the project staff will meet to discuss the results and progress to date; review cases
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - Invasive Breast
Cancer
Subject took
medication for 5
years with
median 81
month follow-up
reported … Incidence
rates/risks of
gynecologic
conditions
Median 81
month follow-
up reported
Good/Good … Invasive Breast
Cancer
Subject took
medication for 5
years with
median 81
month follow-up
reported